Brazil · Delayed Price · Currency is BRL Raia Drogasil Earnings Call Transcripts
Fiscal Year 2026
-
Q3 sales grew 16% YoY, with market-share gains, BRL 1bn+ EBITDA and adjusted net income of BRL 439m. GLP-1 growth is moderating, while expansion, digital investment and gradual margin improvement remain priorities.
-
Q2 2026 saw robust revenue and EBITDA growth, driven by digital expansion, market share gains, and operational efficiency. GLP-1 and digital channels remain key growth drivers, while leverage dropped to 0.8x EBITDA and cash generation was strong.
-
Q1 2026 saw 20% revenue growth, 70% higher net income, and strong digital expansion, with market share up 150 bps and stable margins. Efficiency gains, inventory reduction, and successful 4Bio divestment support a positive outlook despite regulatory and competitive pressures.
Fiscal Year 2025
-
Record Q4 2025 results with 23% retail growth, 170 bps market share gain, and strong digital expansion. Strategic 4Bio sale sharpened focus on core retail, while disciplined capital allocation and operational efficiency drove margin improvements.
-
Q3 2025 saw robust revenue and EBITDA growth, driven by strong retail and digital performance, improved cost control, and record market share. Inventory and cash cycle improvements, new distribution centers, and digital expansion position the company for continued growth.
-
Strong sales and digital growth drove a 12% revenue increase and record net income, with market share gains across all regions. Inventory and expense efficiencies improved margins, while digital and retail segments both delivered robust performance.
-
1Q25 results missed expectations due to calendar effects, lower demand, and increased losses, but market share and digital sales grew. Gross margin and EBITDA declined, with management focusing on cost controls, targeted promotions, and digital expansion to offset ongoing pressures.
Fiscal Year 2024
-
Gross revenue rose 15.1% to BRL 41.8 billion, with digital sales up 41.7% and EBITDA at BRL 3 billion. Despite Q4 softness in cosmetics and margin pressures from tax and mix effects, the company plans 330–350 new stores in 2025 and targets efficiency gains.
-
Q3 saw record revenue, margin expansion, and robust digital growth, with 72 new stores opened and strong free cash flow. Market share and customer satisfaction remain high, and management expects continued margin gains and expansion into Q4.
-
Q2 2024 saw record revenue of BRL 10.4 billion (+15.4% YoY), strong digital growth (+44%), and mature store growth above inflation. Gross margin was pressured by regulatory and tax changes, but EBITDA and net profit remained robust. Expansion and digitalization continue to drive market share gains.